Gates Package — page 868
of 1375 pages
← p.867 p.869 → · this page in the original PDF · package
treatment and cure
I
>
8 AM
AID) [E]
ny (NIH/NIAID)
I
I
>
will likely discuss is the
Are there any new
»f this partnership.
iteration of this strategy has been completed, now on to version 2.0. Last, the plans for an bNAb treatment and cure
trial in Africa with BMGF is moving forward. Waiting for BMGF to finish production of the bNAbs.
This continues to be parallel and complementary activities with BMGF.
Best regards,
Carl
From: Collins, Francis (NIH/NHGRI) [E]
@nih.gov>
Sent: Tuesday, September 27, 2022 6:48 AM
To: Gibbons, Gary (NIH/NHLBI) [E]
@nih.gov>; Panepinto, Julie (NIH/NHLBI) [E]
@nih.gov>; Dieffenbach, Carl (NIH/NIAID) [E]
@niaid.nih.gov>; Fauci, Anthony (NIH/NIAID)
[E]
@niaid.nih.gov>
Cc: Tabak, Lawrence (NIH/OD) [E]
@nih.gov>; Schwetz, Tara (NIH/OD) [E]
@nih.gov>
Subject: Seeing Bill Gates tomorrow
Hi all,
Bill Gates is at the White House tomorrow and asked to see me at 9 AM. Among the topics we will likely discuss is the
HIV-SCD joint NIH-BMGF effort to develop cures that will be applicable in low income settings. Are there any new
developments since the Sunnylands meeting back in May? Bill will likely ask about the future of this partnership.
Thanks, Francis
This is our OCR of the page, with running headers and footers removed. The
Committee's PDF
is authoritative; quote from it. Machine-readable, including the uncleaned
text: /api/page/gates/868
Records on this page
| Record | Date | Type | Pages |
|---|---|---|---|
| gates:email:00754 | — | 867–868 | |
| Seeing Bill Gates tomorrow | 2022-09-27 | 868–869 |